Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Intervalo de ano de publicação
3.
Minerva Ginecol ; 59(5): 481-9, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17912174

RESUMO

AIM: The aim of this study was to compare the efficacy and tolerability of atosiban vs ritodrine administered as single-drug or as combination therapy with the COX inhibitor ketoprofen in the treatment of preterm labor and to investigate how frequent is the need for combination therapy with ketoprofen. METHODS: Ninety-one women with diagnosis of threatened preterm delivery at 24-33 weeks' gestation were enrolled in an observational case-control study. Forty-seven received IV atosiban (6.75 mg initial dose, 300 microg/min loading dose for 3 hours, 100 microg/min maintenance dose for 48-96 hours) and 44 IV ritodrine (0.05-0.3 mg/min). When response to the first drug in the first 2-4 hours was unsatisfactory, ketoprofen was added (100 mg loading dose IV and 100-150 mg maintenance dose every 12 hours) for a maximum of 48 hours. RESULTS: Ketoprofen was added in 51.1% of the atosiban group and 47.7% of the ritodrine group (P 0.75, not statistically significant). The percentages of women non delivered in the two groups were 85.1% vs 81.8% at 48 hours (P=0.44) and 59.6% vs 54.5% at 7 days (P=0.39). One woman treated with atosiban reported transient dyspnea at the administration of the bolus dose; 20.5% of women who received ritodrine developed tachycardia and 4.5% dyspnea (P=0.001). Neonatal mortality and morbidity were comparable in both groups and unrelated to ketoprofen exposure. CONCLUSION: Atosiban efficacy was comparable to ritodrine, but with a superior safety profile. A large proportion of women in both groups required second-line ketoprofen therapy, with comparable neonatal outcomes.


Assuntos
Inibidores de Ciclo-Oxigenase/uso terapêutico , Cetoprofeno/uso terapêutico , Trabalho de Parto Prematuro/tratamento farmacológico , Trabalho de Parto Prematuro/prevenção & controle , Ritodrina/uso terapêutico , Tocolíticos/uso terapêutico , Vasotocina/análogos & derivados , Adulto , Estudos de Casos e Controles , Quimioterapia Combinada , Feminino , Humanos , Itália , Gravidez , Segundo Trimestre da Gravidez , Terceiro Trimestre da Gravidez , Resultado do Tratamento , Contração Uterina/efeitos dos fármacos , Vasotocina/uso terapêutico
4.
Rev Argent Microbiol ; 38(3): 130-3, 2006.
Artigo em Espanhol | MEDLINE | ID: mdl-17152209

RESUMO

Mycoplasma suis is a swine erythrocyte obligatory parasite. Its presence may result in chronic or acute anaemia in different pig categories. It is considered that the postweaning multisystemic wasting syndrome (PMWS) is caused by porcine circovirus type 2, but some aspects of the pathogenesis remain unknown. PMWS signs are impaired weight gain, anaemia and jaundice in 5 to 12 week-old pigs that suffer from immunosuppression and bacterial co-infections. The pigs with signs of these diseases on three porcine farms were studied. Compatible M. suis forms in blood smears and typical PMWS lesions in tissue cuts were seen. This is the first communication of the clinical association between these two entities.


Assuntos
Mycoplasma/isolamento & purificação , Síndrome Definhante Multissistêmico de Suínos Desmamados/microbiologia , Criação de Animais Domésticos , Animais
5.
Phys Rev Lett ; 93(23): 230801, 2004 Dec 03.
Artigo em Inglês | MEDLINE | ID: mdl-15601138

RESUMO

A search for an annual variation of a daily sidereal modulation of the frequency difference between colocated 129Xe and 3He Zeeman masers sets a stringent limit on boost-dependent Lorentz and CPT violation involving the neutron, consistent with no effect at the level of 150 nHz. In the framework of the general standard-model extension, the present result provides the first clean test for the fermion sector of the symmetry of spacetime under boost transformations at a level of 10(-27) GeV.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...